We have proven our capabilities in multiple partnerships throughout the US and Europe and a number of antibodies from our discovery platform are currently in clinical development in various indications with high medical need.
We have proven our capabilities in multiple partnerships throughout the US and Europe and a number of antibodies from our discovery platform are currently in clinical development in various indications with high medical need.